SUPN Supernus Pharmaceuticals, Inc.
Healthcare$48.21-2.37%ClosedMarket Cap: $2.80B
As of 2026-05-25
Analyst Consensus
Consensus
Buy
Target (Consensus)
$60.00
Target (Median)
$60.00
Target Range
$55.00 - $65.00
Upside from current price: 24.5%
Rating Distribution
1 Strong Buy4 Buy1 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
| Date | Firm | Action | Rating | Previous |
|---|---|---|---|---|
| 2025-12-19 | Stifel | maintain | Hold | Hold |
| 2025-10-23 | TD Cowen | maintain | Buy | Buy |
| 2025-10-09 | Piper Sandler | upgrade | Overweight | Neutral |
| 2025-09-30 | Cantor Fitzgerald | maintain | Overweight | Overweight |
| 2025-08-29 | Piper Sandler | maintain | Neutral | Neutral |
| 2025-08-06 | Cantor Fitzgerald | maintain | Overweight | Overweight |
Forward Estimates
| Period | EPS Est. | Revenue Est. | # Analysts |
|---|---|---|---|
| Fri Dec 31 | $3.94 | $1.02B | 3 |
| Sun Dec 31 | $5.38 | $1.17B | 2 |
| Mon Dec 31 | $6.88 | $1.30B | 1 |
| Tue Dec 31 | $6.99 | $1.36B | 1 |